PMO Interview with the Innovator Series: Volume 3
Kimberly J. Popovits
Video Categories: PMO Interview with the Innovator Series
Dr. Mesa recognizes that although genotypic data is not yet being used to select treatment choice or dosing in myelofibrosis, it is used to address the issues of prognosis and burden of disease.
Listen as Ken Schaecher, MD describes the rule of ACOs in helping to manage oncology costs and how they impact oncology care.Supported through funding from Incyte